DE2119688C3 - Herstellung von Impfstoffen mit lebenden Viren - Google Patents

Herstellung von Impfstoffen mit lebenden Viren

Info

Publication number
DE2119688C3
DE2119688C3 DE2119688A DE2119688A DE2119688C3 DE 2119688 C3 DE2119688 C3 DE 2119688C3 DE 2119688 A DE2119688 A DE 2119688A DE 2119688 A DE2119688 A DE 2119688A DE 2119688 C3 DE2119688 C3 DE 2119688C3
Authority
DE
Germany
Prior art keywords
viruses
quail
virus
chicken
eggs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2119688A
Other languages
German (de)
English (en)
Other versions
DE2119688A1 (de
DE2119688B2 (de
Inventor
Takeo Konobe
Koichi Ono
Tetsuo Onoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation for Microbial Diseases of Osaka University BIKEN
Original Assignee
Research Foundation for Microbial Diseases of Osaka University BIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation for Microbial Diseases of Osaka University BIKEN filed Critical Research Foundation for Microbial Diseases of Osaka University BIKEN
Publication of DE2119688A1 publication Critical patent/DE2119688A1/de
Publication of DE2119688B2 publication Critical patent/DE2119688B2/de
Application granted granted Critical
Publication of DE2119688C3 publication Critical patent/DE2119688C3/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE2119688A 1970-04-22 1971-04-22 Herstellung von Impfstoffen mit lebenden Viren Expired DE2119688C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3527470A JPS5013333B1 (enExample) 1970-04-22 1970-04-22

Publications (3)

Publication Number Publication Date
DE2119688A1 DE2119688A1 (de) 1971-11-04
DE2119688B2 DE2119688B2 (de) 1979-08-09
DE2119688C3 true DE2119688C3 (de) 1980-04-24

Family

ID=12437194

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2119688A Expired DE2119688C3 (de) 1970-04-22 1971-04-22 Herstellung von Impfstoffen mit lebenden Viren

Country Status (9)

Country Link
JP (1) JPS5013333B1 (enExample)
BE (1) BE766093A (enExample)
CA (1) CA955850A (enExample)
CH (1) CH563459A5 (enExample)
DE (1) DE2119688C3 (enExample)
FR (1) FR2092068B1 (enExample)
GB (1) GB1349362A (enExample)
IT (1) IT1001467B (enExample)
NL (2) NL173598C (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA743771B (en) * 1973-07-19 1975-07-30 M Sevoian Vaccine and preparation thereof

Also Published As

Publication number Publication date
DE2119688A1 (de) 1971-11-04
NL173598B (nl) 1983-09-16
FR2092068B1 (enExample) 1977-04-15
GB1349362A (en) 1974-04-03
BE766093A (fr) 1971-09-16
NL173598C (nl) 1984-02-16
FR2092068A1 (enExample) 1972-01-21
IT1001467B (it) 1976-04-20
NL8303134A (nl) 1984-01-02
CA955850A (en) 1974-10-08
JPS5013333B1 (enExample) 1975-05-19
DE2119688B2 (de) 1979-08-09
NL7105497A (enExample) 1971-10-26
CH563459A5 (enExample) 1975-06-30

Similar Documents

Publication Publication Date Title
London et al. Brain tumors in owl monkeys inoculated with a human polyomavirus (JC virus)
Stanley et al. STUDIES ON THE PATHOGENESIS OF A HITHERTO UNDESCRIBED VIRUS (HEPATO-ENCEPHALOMYE-LITIS) PRODUCING UNUSUAL SYMPTOMS IN SUCKLING MICE.
DE69935721T2 (de) Kälteadaptierte Pferdeinfluenzaviren
DE69732407T2 (de) Verfahren für die replikation von influenza in zellkultur und die bei diesem verfahren hergestellten influenza-viren
Eaton et al. Studies on the etiology of primary atypical pneumonia: II. Properties of the virus isolated and propagated in chick embryos
Becker et al. Experimental infection of chickens with influenza A/Tern/South Africa/1961 and Chicken/Scotland/1959 viruses: I. Clinical picture and virology
DE2119688C3 (de) Herstellung von Impfstoffen mit lebenden Viren
Perelman et al. Pox in ostriches
Shaw Cultivation of Coxsackie virus in embryonated eggs and in chick tissue cultures
Jackson et al. The epizootiology of Marek's disease 3. The interrelationship of virus pathogenicity, antibody and the incidence of Marek's disease
Varley et al. The response of chickens to experimental infection with strains of M. gallisept1cum of different virulence and M. g allinarum
Wise et al. Experimental reproduction of turkey syndrome’65 with Mycoplasma meleagridis
Hohlstein et al. An epiornithic of avian encephalomyelitis in turkeys in Minnesota
Mancini et al. Cultivation of avian encephalomyelitis virus in vitro. 1. In chick embryo neuroglial cell culture
Spradbrow Appropriate vaccination and therapies for rural poultry flocks in developing countries and their relevance to developed countries
Randall et al. Papovavirus‐like infection in budgerigars (Melopsittacus Undulatus)
DE2126957A1 (de) Impfstoff gegen Gänsehepatitis
McKinley Filterable virus and Rickettsia diseases
GOODPASTURE Virus infection of the chick embryo
Dalling Bacillary white diarrhea
Asplin Observations on the Aetiology of Lymphomatosis: III.—The Development of Lymphomatosis in Chickens Free of the “Chick Disease” Virus
Biggs et al. A quantitative sequential study of viraemia and neutralising antibody to HVT and MDV in a commercial flock vaccinated with HVT
Brandly Propagation of fowl-and pigeon-pox viruses in avian eggs and use of egg-cultivated viruses for immunization
Beaudette Infectious bronchitis and Newcastle disease
Bosgra et al. Preparation of virus vaccines by means of tissue cultures

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
8339 Ceased/non-payment of the annual fee